Pfizer’s Prevnar 13® shown to be immunogenic in older children and adolescents
12 March 2012 | By Pfizer
Data from a Phase 3 study of Prevnar 13® met all study endpoints...
List view / Grid view
12 March 2012 | By Pfizer
Data from a Phase 3 study of Prevnar 13® met all study endpoints...
12 March 2012 | By Pfizer
Biocon and Pfizer have announced the conclusion of their alliance...
9 March 2012 | By GlaxoSmithKline
New scheme to offer 40 annual apprenticeships in manufacturing, R&D and IT...
9 March 2012 | By AstraZeneca
The FDA denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with labelling...
8 March 2012 | By Abbott
U.S. FDA clearance for the FreeStyle InsuLinx Blood Glucose Monitoring System...
7 March 2012 | By Primetek Solutions
The new MiniSeal Plus heat sealer from Porvair Sciences operates with a very high force...
7 March 2012 | By Primetek Solutions
The Ultrajet pipette controller from Porvair Sciences is an easy-to-use electronic pipette filler...
7 March 2012 | By Primetek Solutions
Many scientists around the world have come to rely upon the Porvair Sciences Catalogue as a primary source of information...
7 March 2012 | By Primetek Solutions
Porvair Sciences has introduced a low profile deep well microplate...
7 March 2012 | By Primetek Solutions
Constructed in ultra-pure grade polystyrene, the opaque white Krystal 2000 plate from Porvair Sciences Ltd...
7 March 2012 | By Primetek Solutions
Krystal™ glass bottom plates provide unmatched performance for whole-plate CCD imaging and laser detection applications....
7 March 2012 | By Abbott
The U.S. FDA approved the Absolute Pro® Vascular Self-Expanding Stent System...
7 March 2012 | By Eli Lilly and Company
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced Jentadueto™ (linagliptin/metformin hydrochloride) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S.
7 March 2012 | By Gilead Sciences Inc
Quad currently under review for marketing approval...
7 March 2012 | By Novartis
A study found that the investigational drug Signifor®, normalized cortisol levels...